Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Asset Writedowns and Impairment (2018 - 2023)

Historic Asset Writedowns and Impairment for Viemed Healthcare (VMD) over the last 6 years, with Q1 2023 value amounting to $4.1 million.

  • Viemed Healthcare's Asset Writedowns and Impairment rose 1991.29% to $4.1 million in Q1 2023 from the same period last year, while for Mar 2023 it was $10.7 million, marking a year-over-year increase of 2553.69%. This contributed to the annual value of $10.0 million for FY2022, which is 4519.22% up from last year.
  • Viemed Healthcare's Asset Writedowns and Impairment amounted to $4.1 million in Q1 2023, which was up 1991.29% from $2.2 million recorded in Q4 2022.
  • In the past 5 years, Viemed Healthcare's Asset Writedowns and Impairment ranged from a high of $4.1 million in Q1 2023 and a low of $1.5 million during Q3 2020
  • In the last 5 years, Viemed Healthcare's Asset Writedowns and Impairment had a median value of $2.1 million in 2019 and averaged $2.4 million.
  • In the last 5 years, Viemed Healthcare's Asset Writedowns and Impairment tumbled by 5279.4% in 2020 and then skyrocketed by 8938.98% in 2022.
  • Quarter analysis of 5 years shows Viemed Healthcare's Asset Writedowns and Impairment stood at $2.9 million in 2019, then decreased by 27.45% to $2.1 million in 2020, then decreased by 21.1% to $1.6 million in 2021, then skyrocketed by 33.74% to $2.2 million in 2022, then skyrocketed by 87.77% to $4.1 million in 2023.
  • Its Asset Writedowns and Impairment was $4.1 million in Q1 2023, compared to $2.2 million in Q4 2022 and $1.5 million in Q3 2022.